2Q EARNINGS: Onyx mum on buyout; Kyprolis misses consensus
This article was originally published in Scrip
Executive Summary
More than one potential acquirer is considering a purchase of Onyx Pharmaceuticals, chairman and CEO Tony Coles said during the company's second quarter earnings conference call on 8 August, but he declined to provide any further commentary on a buyer or transaction.